Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) DOI:10.1039/D0CS00310G
Conjugation methods for ADC development. ADC production using... | Download Scientific Diagram
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index | Nature Biotechnology
Synthesis of precision antibody conjugates using proximity-induced chemistry
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) DOI:10.1039/D0CS00310G
Antibodies | Free Full-Text | Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) DOI:10.1039/D0CS00310G
Computationally designed antibody–drug conjugates self-assembled via affinity ligands | Nature Biomedical Engineering
Strategies and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery
Antibody drug conjugate: the “biological missile” for targeted cancer therapy | Signal Transduction and Targeted Therapy
One-Step Conjugation Method for Site-Specific Antibody–Drug Conjugates through Reactive Cysteine-Engineered Antibodies | Bioconjugate Chemistry
Antibody-drug conjugates—an emerging class of cancer treatment | British Journal of Cancer
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition | Nature Communications
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies - Tarantino - 2022 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology
Antibody–drug conjugates | Nature Reviews Drug Discovery
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates | Nature Communications
Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology
The clinical development of antibody–drug conjugates — lessons from leukaemia | Nature Reviews Clinical Oncology
Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice | Nature Communications
Antibody–drug conjugates: Recent advances in linker chemistry - ScienceDirect
Antibody drug conjugate: the “biological missile” for targeted cancer therapy | Signal Transduction and Targeted Therapy
Comparison of Analytical Methods for Antibody–Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP | Analytical Chemistry
